Lubrizol will showcase the benefits of its polymer-based excipients for the solubility, bioavailability and palatability of APIs and nutraceuticals at CPHI Frankfurt (28th- 30th October 2025 at Stand 8.0M71).
Dr. Subhashis Chakraborty, general manager, head - global product management at ACG Capsules discusses the European Commission's decision on titanium dioxide in pharmaceuticals.
Biosynth, a developer and supplier of critical raw materials and services for life sciences and diagnostics, has announced the opening of its expanded GMP bioconjugation facility at its existing Berlin site.
Bachem has announced investment across their site network, with new funding to improve production facilities at their Bubendorf, Vista and St Helens sites, along with a new site in Sisseln.
Lonza, a contract development and manufacturing organisation (CDMO), has announced the launch of its new Design2Optimize platform to enhance process development and manufacturing of small molecule APIs.
Solids handling equipment maker, Ajax Equipment, has supplied pharmaceutical developer and manufacturer, Sterling Pharma Solutions, with an ATEX-rated agitated screw feeder mounted on a mobile frame to feed an active pharmaceutical ingredient (API).
IFF Pharma Solutions has announced the launch of Low Nitrite METHOCEL hydroxypropyl methylcellulose (HPMC), a range of low nitrite cellulose ethers developed to reduce the risk of nitrosamine formation in finished pharmaceutical dosages.
C2 PHARMA has announced the approval of a Certificate of Suitability (CEP) for Oxybuprocaine Hydrochloride by the European Directorate for the Quality of Medicines and Health Care (EDQM).
